Work

A phase II study of atezolizumab in combination with bevacizumab in patients with recurrent, persistent or metastatic cervical cancer

Year: 2019

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2019.04.045

Authors: C.F. Friedman, A. Snyder, E. Sharon, A. Buckley De Meritens, L.A. Cantrell, B.R. Corr, J. Konner, P.A. Konstantinopoulos, K. Soldan, C.A. Aghajanian, D. Zamarin

Institutions: Memorial Sloan Kettering Cancer Center, National Cancer Institute, Rutgers Cancer Institute, University of Virginia, University of Colorado Anschutz, University of Colorado Denver, Dana-Farber Cancer Institute, Weill Cornell Medicine

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2953769340

FWCI: 1.873

Cites:

Cited by: 10

Related to: 10